• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖-羧甲基罗望子胶核粉互聚物络合:结肠给药研究

Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug delivery.

作者信息

Kaur Gurpreet, Jain Subheet, Tiwary Ashok K

机构信息

Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, 147002, India.

出版信息

Sci Pharm. 2010 Jan-Mar;78(1):57-78. doi: 10.3797/scipharm.0908-10. Epub 2009 Dec 3.

DOI:10.3797/scipharm.0908-10
PMID:21179370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3002829/
Abstract

The present study was aimed at evaluating the possible use of inter polymer complexed (IPC) films of chitosan (CH) and carboxymethyl tamarind kernel powder (CMTKP) for colon release of budesonide. Viscosity analysis of the supernatant liquid obtained after reacting CH and CMTKP in different proportions revealed 40:60 to be the optimum stoichiometric ratio. The FTIR spectra of IPC films formed from 50:50 or 40:60 ratio of CH:CMTKP did not reveal any reduction in the peaks at 1560cm(â1) and 1407cm(â1) after exposure to pH 1.2, suggesting resistance of the interaction between âCOO(â) groups of CMTKP and âNH(3) (+) groups of CH to gastric pH. Tablets containing Avicel pH 102 as diluent and coated to a weight gain of 10%, w/w with aqueous solutions of 40:60 or 50:50 ratio of CH:CMTKP did not release budesonide in pH 1.2 buffer. Histopathology of the rat colon after oral administration of these IPC film coated tablets revealed significantly greater (p<0.05) reduction in TNBS-induced ulcerative colitis as compared to that after administration of uncoated tablets. The Cmax of budesonide achieved after oral administration of these IPC film coated tablets was comparable to that observed after administration of uncoated tablets. The results strongly indicate versatility of CH-CMTKP IPC films to deliver budesonide in the colon.

摘要

本研究旨在评估壳聚糖(CH)与羧甲基罗望子核粉(CMTKP)的聚合物间复合物(IPC)薄膜用于布地奈德结肠释放的可能性。对CH和CMTKP按不同比例反应后获得的上清液进行粘度分析,结果显示40:60为最佳化学计量比。由CH:CMTKP比例为50:50或40:60形成的IPC薄膜在暴露于pH 1.2后,其傅里叶变换红外光谱(FTIR)在1560cm⁻¹和1407cm⁻¹处的峰没有任何降低,这表明CMTKP的-COO⁻基团与CH的-NH₃⁺基团之间的相互作用对胃内pH具有抗性。含有微晶纤维素pH 102作为稀释剂且用CH:CMTKP比例为40:60或50:50的水溶液包衣至增重10%(w/w)的片剂在pH 1.2缓冲液中不释放布地奈德。口服这些IPC薄膜包衣片剂后大鼠结肠的组织病理学显示,与口服未包衣片剂相比,三硝基苯磺酸(TNBS)诱导的溃疡性结肠炎的减轻程度显著更大(p<0.05)。口服这些IPC薄膜包衣片剂后布地奈德达到的Cmax与口服未包衣片剂后观察到的相当。结果有力地表明CH-CMTKP IPC薄膜在结肠中递送布地奈德具有多功能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/f1f627e8ac36/Scipharm.2010.78.57f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/c528c529524d/Scipharm.2010.78.57f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/f1c908f64932/Scipharm.2010.78.57f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/c65cc60c0f39/Scipharm.2010.78.57f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/66a7eab5c2b1/Scipharm.2010.78.57f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/1adde71e05e7/Scipharm.2010.78.57f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/9c8096d2af48/Scipharm.2010.78.57f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/226807a8295f/Scipharm.2010.78.57f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/f1f627e8ac36/Scipharm.2010.78.57f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/c528c529524d/Scipharm.2010.78.57f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/f1c908f64932/Scipharm.2010.78.57f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/c65cc60c0f39/Scipharm.2010.78.57f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/66a7eab5c2b1/Scipharm.2010.78.57f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/1adde71e05e7/Scipharm.2010.78.57f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/9c8096d2af48/Scipharm.2010.78.57f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/226807a8295f/Scipharm.2010.78.57f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c5/3002829/f1f627e8ac36/Scipharm.2010.78.57f8.jpg

相似文献

1
Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug delivery.壳聚糖-羧甲基罗望子胶核粉互聚物络合:结肠给药研究
Sci Pharm. 2010 Jan-Mar;78(1):57-78. doi: 10.3797/scipharm.0908-10. Epub 2009 Dec 3.
2
Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex.结肠递药:壳聚糖-硫酸软骨素互聚物复合物的评估。
AAPS PharmSciTech. 2010 Mar;11(1):36-45. doi: 10.1208/s12249-009-9353-8. Epub 2009 Dec 17.
3
Investigations on interpolymer complexes of cationic guar gum and xanthan gum for formulation of bioadhesive films.用于制备生物粘附性薄膜的阳离子瓜尔胶与黄原胶的互聚物复合物研究。
Res Pharm Sci. 2010 Jul;5(2):79-87.
4
Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.制备并评价布地奈德大鼠实验性溃疡性结肠炎葡聚糖基质片剂的体内外评价。
Drug Deliv. 2011 Feb;18(2):122-30. doi: 10.3109/10717544.2010.520352. Epub 2010 Oct 18.
5
Carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic drug delivery.羧甲基罗望子胶纳米粒用于眼部药物传递。
Int J Biol Macromol. 2012 Apr 1;50(3):833-9. doi: 10.1016/j.ijbiomac.2011.11.017. Epub 2011 Nov 28.
6
Pectin Film Coated Pellets for Colon-targeted Delivery of Budesonide: In-vitro/In-vivo Evaluation in Induced Ulcerative Colitis in Rat.用于布地奈德结肠靶向递送的果胶膜包衣微丸:大鼠诱导性溃疡性结肠炎的体外/体内评价
Iran J Pharm Res. 2012 Summer;11(3):733-45.
7
Quality by Design Approach for Optimization of Microbial and pH-Triggered Colon-Targeted Tablet Formulation Using Carboxymethyl Tamarind Gum.采用羧甲基罗望子胶的微生物和 pH 触发结肠靶向片剂制剂的优化的质量源于设计方法。
Assay Drug Dev Technol. 2023 Oct;21(7):297-308. doi: 10.1089/adt.2023.066.
8
Exploiting the synergistic effect of chitosan-EDTA conjugate with MSA for the early recovery from colitis.利用壳聚糖-EDTA 缀合物与 MSA 的协同作用,实现结肠炎的早期恢复。
Int J Biol Macromol. 2013 Mar;54:186-96. doi: 10.1016/j.ijbiomac.2012.12.026. Epub 2012 Dec 25.
9
Site Targeted Press Coated Delivery of Methylprednisolone Using Eudragit RS 100 and Chitosan for Treatment of Colitis.使用欧巴代RS 100和壳聚糖进行甲基强的松龙的靶向部位压片包衣给药治疗结肠炎
Recent Pat Antiinfect Drug Discov. 2016;11(1):32-43. doi: 10.2174/1574891x10666150917115218.
10
Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.用于结肠特异性给药系统的壳聚糖基控孔渗透泵:制剂变量筛选及体外研究
Int J Pharm. 2007 Mar 6;332(1-2):115-24. doi: 10.1016/j.ijpharm.2006.09.038. Epub 2006 Sep 29.

引用本文的文献

1
succinate based polyelectrolyte complexes for colon delivery of synbiotic in management of inflammatory bowel disease.用于在炎症性肠病管理中结肠递送合生元的基于琥珀酸盐的聚电解质复合物
Heliyon. 2024 Apr 9;10(8):e29429. doi: 10.1016/j.heliyon.2024.e29429. eCollection 2024 Apr 30.
2
Carboxymethylated Gums and Derivatization: Strategies and Significance in Drug Delivery and Tissue Engineering.羧甲基化胶及其衍生化:药物递送与组织工程中的策略及意义
Pharmaceuticals (Basel). 2023 May 22;16(5):776. doi: 10.3390/ph16050776.
3
Investigations on interpolymer complexes of cationic guar gum and xanthan gum for formulation of bioadhesive films.

本文引用的文献

1
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.1. 药物递送分析指数模型述评:原创研究文章:溶质释放描述的一个简单方程:I II. 平板、球体、圆柱体或圆盘形式的非溶胀装置中的菲克和非菲克释放,1987年。
J Control Release. 2014 Sep 28;190:31-2.
2
Colonic drug delivery.结肠给药
Drug Discov Today Technol. 2005 Spring;2(1):33-7. doi: 10.1016/j.ddtec.2005.05.021.
3
Metal complexes of crosslinked chitosans Part II. An investigation of their hydrolysis to chitooligosaccharides using chitosanase.
用于制备生物粘附性薄膜的阳离子瓜尔胶与黄原胶的互聚物复合物研究。
Res Pharm Sci. 2010 Jul;5(2):79-87.
交联壳聚糖的金属配合物 第二部分。使用壳聚糖酶将其水解为壳寡糖的研究。
Int J Biol Macromol. 2007 Dec 1;41(5):491-6. doi: 10.1016/j.ijbiomac.2007.06.009. Epub 2007 Jun 30.
4
Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system.用于口服部位特异性给药系统的双交联海藻酸盐-壳聚糖共混凝胶珠的制备及体外控释
Int J Pharm. 2007 May 24;336(2):329-37. doi: 10.1016/j.ijpharm.2006.12.019. Epub 2006 Dec 20.
5
Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes.尤特奇E PO/尤特奇L 100-55聚电解质复合物的物理化学表征及药物释放特性
Eur J Pharm Biopharm. 2006 May;63(1):26-36. doi: 10.1016/j.ejpb.2005.10.005. Epub 2005 Dec 27.
6
A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.用于回肠-结肠给药的pH响应性聚合物药物释放性能的体外比较评估。
Int J Pharm. 2006 Feb 3;308(1-2):52-60. doi: 10.1016/j.ijpharm.2005.10.038. Epub 2005 Dec 13.
7
Development and validation of a high-performance liquid chromatographic method for the analysis of budesonide.布地奈德分析的高效液相色谱法的建立与验证
J Pharm Biomed Anal. 2006 Feb 13;40(2):423-8. doi: 10.1016/j.jpba.2005.06.038. Epub 2005 Sep 6.
8
Chitosan-alginate multilayer beads for controlled release of ampicillin.用于氨苄西林控释的壳聚糖-海藻酸盐多层珠粒
Int J Pharm. 2005 Feb 16;290(1-2):45-54. doi: 10.1016/j.ijpharm.2004.11.015. Epub 2005 Jan 5.
9
New oral delivery systems for treatment of inflammatory bowel disease.用于治疗炎症性肠病的新型口服给药系统。
Adv Drug Deliv Rev. 2005 Jan 6;57(2):247-65. doi: 10.1016/j.addr.2004.08.011.
10
Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications.用于生物医学应用的通过络合或聚集形成的壳聚糖水凝胶的结构与相互作用。
Eur J Pharm Biopharm. 2004 Jan;57(1):35-52. doi: 10.1016/s0939-6411(03)00160-7.